IMMUNOLOGICAL MECHANISMS OF NEPHRITIS IN CHILDHOOD
IMMUNOLOGICAL MECHANISMS OF NEPHRITIS IN CHILDHOOD
批准号:
2517517
负责人:
Morris Reichlin
金额:
$21.27万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-09-30 至 1999-08-31
关键词:
DNA antiantibody antibody formation antigen antibody reaction autoantibody binding proteins calcium flux cell cell interaction cell death child (0-11) clinical chemistry enzyme linked immunosorbent assay epitope mapping fluorescent dye /probe gel electrophoresis human subject immunopathology membrane potentials nephritis nucleic acid inhibitor nucleic acid structure protein sequence ribosomal proteins systemic lupus erythematosus
中文摘要
儿童系统性红斑狼疮(SLE)与疾病的不同之处在于
成人受肾炎的患病率较高。我们假设这是
肾炎的高患病率是由几种类型的肾炎引起的
在儿童时期的系统性红斑狼疮中同时出现的自身抗体。我们的
这些自身抗体的两个主要候选者是针对
DsDNA长期以来一直被认为在成人狼疮中发挥作用
肾炎和抗核糖体“P”蛋白自身抗体
以前有报道称与成人或儿童狼疮有关
肾炎。我们认为,在某些患者中,Ro/SSA抗体也可能
发挥引发肾病的作用。除了最近的初步临床和
支持抗P抗体在狼疮性肾炎中的作用的动物数据,两者都是抗P抗体
DsDNA和抗核糖体“P”抗体最近被发现
含有直接结合和损伤细胞的抗体亚群
在文化上。这种体外细胞损伤被认为是一种替代
它们在体内的免疫致病潜能。我们建议定义
这些自身抗体在个体患者中的致病潜力
亲和纯化自身抗体及其相互作用的研究
肾细胞在培养中。我们将描述这种模式
细胞内定位及其对细胞功能和活力的影响。
我们还将描述抗dsdna的不同致病机制。
来自个别患者的初步研究已经表明
某些人类抗体通过补体依赖机制损伤细胞
细胞表面和其他物质穿透细胞,定位于
细胞核或细胞质,并在更长的时间内影响细胞功能
一段时间。我们将把这些免疫致病特性与
体外配合患者的临床状态。
我们相信这样的研究可能会产生数据,这些数据将培育出新的
儿童狼疮性肾炎发病机制的研究进展
为管理这一问题提出新的战略和干预措施
严重的并发症。
英文摘要
Childhood systemic lupus erythematosus (SLE) differs from the disease in
adults by a higher prevalence of nephritis. We hypothesize that this
higher prevalence of nephritis is due to several types of nephritogenic
autoantibodies that occur concurrently in the childhood form of SLE. Our
two major candidates for these autoantibodies are those directed against
dsDNA which have long been recognized to play a role in adult lupus
nephritis and autoantibodies to ribosomal "P" protein which have not been
reported previously to be associated with either adult or pediatric lupus
nephritis. We propose that in some patients antibodies to Ro/SSA may also
play a nephritogenic role. Aside from recent preliminary clinical and
animal data that support a role for anti-P in lupus nephritis, both anti-
dsDNA and anti-ribosomal "P" antibodies have recently been found to
contain subpopulations of antibodies that directly bind and injure cells
in culture. This in vitro cell injury is hypothesized to be a surrogate
for their immunopathogenic potential in vivo. We propose to define the
pathogenic potential of these autoantibodies in individual patients by
affinity purifying their autoantibodies and by studying their interaction
with renal cells in culture. We will characterize the pattern of
intracellular localization and the effects on cell function and viability.
We will also characterize the diverse pathogenic mechanism of anti-dsDNA
from individual patients as preliminary studies already have shown that
some human antibodies injure cells by a complement dependent mechanism at
the cell surface and others penetrate the cell, localize in either the
nucleus or the cytoplasm, and affect cellular function over a longer
period of time. We will correlate these immunopathogenetic properties in
vitro with the patients clinical status.
We believe such studies may generate data which will foster a new
perspective on the mechanism of lupus nephritis in children and may
suggest new strategies and interventions for the management of this
serious complication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sample Procurement and Management Core
-
批准号:7938657
-
项目类别:
-
资助金额:$11.71万
-
财政年份:2009
-
负责人:Morris Reichlin
-
依托单位:
Sample Procurement and Management Core
-
批准号:7673677
-
项目类别:
-
资助金额:$11.39万
-
财政年份:2008
-
负责人:Morris Reichlin
-
依托单位:
Sample Procurement and Management Core
-
批准号:7325053
-
项目类别:
-
资助金额:$9.8万
-
财政年份:2007
-
负责人:Morris Reichlin
-
依托单位:
Oklahoma Specialized Center of Research in SLE
-
批准号:7125194
-
项目类别:
-
资助金额:$115.5万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
BIOMED RES FACIL IMPROV : BONE DENSITY
-
批准号:6794414
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
BIOMED RES FACIL IMPROV : IMMUN DIS
-
批准号:6794417
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
IRB Inovation at a Private Research Foundation
-
批准号:6591618
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
IMPROVEMENT OF BIOMEDICAL RESEARCH FACILITY
-
批准号:6541160
-
项目类别:
-
资助金额:$91.16万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
BIOMED RES FACIL IMPROV : SLE
-
批准号:6794416
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
Oklahoma Specialized Center of Research in SLE
-
批准号:6793968
-
项目类别:
-
资助金额:$115.5万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
Oklahoma Specialized Center of Research in SLE
-
批准号:6531904
-
项目类别:
-
资助金额:$115.5万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
BIOMED RES FACIL IMPROV : NERVOUS SYSTEM
-
批准号:6794418
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
Oklahoma Specialized Center of Research in SLE
-
批准号:6656256
-
项目类别:
-
资助金额:$115.5万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
Oklahoma Specialized Center of Research in SLE
-
批准号:6949730
-
项目类别:
-
资助金额:$115.5万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
BIOMED RES FACIL IMPROV : DIABETES
-
批准号:6794415
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
PLANNING GRANT FOR A MULTIPURPOSE CLINICAL RES CENTER
-
批准号:6076195
-
项目类别:
-
资助金额:$16.15万
-
财政年份:1999
-
负责人:Morris Reichlin
-
依托单位:
REGULATION OF AUTOANTIBODIES TO RIBOSOMAL P PROTEINS
-
批准号:6170695
-
项目类别:
-
资助金额:$8.08万
-
财政年份:1998
-
负责人:Morris Reichlin
-
依托单位:
IMMUNOLOGICAL MECHANISMS OF NEPHRITIS IN CHILDHOOD SLE
-
批准号:6128376
-
项目类别:
-
资助金额:$30.36万
-
财政年份:1995
-
负责人:Morris Reichlin
-
依托单位:
IMMUNOLOGICAL MECHANISMS OF NEPHRITIS IN CHILDHOOD
-
批准号:2083722
-
项目类别:
-
资助金额:$20.01万
-
财政年份:1995
-
负责人:Morris Reichlin
-
依托单位:
IMMUNOLOGICAL MECHANISMS OF NEPHRITIS IN CHILDHOOD
-
批准号:2769639
-
项目类别:
-
资助金额:$22.12万
-
财政年份:1995
-
负责人:Morris Reichlin
-
依托单位: